Have you ever heard any publicity is good publicity. I think it’s great enough people including many doctors and even some politicians badgered the FDA enough that they had to explain themselves. The US FDA explanation would be acceptable if CYDY was trying to get toe fungus cream approved but did not hit primary endpoint. Anyone over those with half a brain would be able to see from all the data that the drug was very effective and beneficial without any safety issues until the patients were stopped being given the drug. Day 0 and Day 7. By day 14 the drug peaked in patients systems and than they began to decline without being given additional leronlimab. It clearly was very beneficial and the FDA is already worried about what they will look like not only in the US but on world stage about why they did not EUA leronlimab. They sent out that letter to explain what we already knew they don’t care about anything but a perfect designed trial that hits any endpoint. It could be out of hospital 2 days early and that’s more important than reduce death by 30-80% in some populations. The failing of endpoints in that trial has been 5x baked into low $3 SP there was no reason for it to drop but all the reasons the past couple Weeks full of great news including huge distribution deals, great financing deals, and getting foot in the door of Brazil and India. I will be loading up on more shares today. This was a short attack using less than 2% of the total float shares able to crash stock 30% is ridiculous.